Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies-Reference-Cited by-同舟云学术

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies

Published:2018-09-11 Issue:71 Volume:9 Page:33528-33535
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chevallier Patrice¹,Peterlin Pierre¹,Garnier Alice¹,Le Bourgeois Amandine¹,Mahé Beatrice¹,Dubruille Viviane¹,Blin Nicolas¹,Touzeau Cyrille¹,Gastinne Thomas¹,Lok Anne¹,Le Bris Yannick²,Béné Marie C.²,Le Gouill Steven¹,Moreau Philippe¹,Guillaume Thierry¹

Affiliation:

1. Hematology Department, CHU Hotel-Dieu, Nantes, France

2. Hematology/Biology Laboratory, CHU Hotel-Dieu, Nantes, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia;International Journal of Molecular Sciences;2024-01-12

2. Phase I study of zoledronic acid combined with escalated doses of interleukine‐2 for early in vivo generation of Vγ9Vδ2 T‐cells after haploidentical stem cell transplant with posttransplant cyclophosphamide;American Journal of Hematology;2024-01-02

3. Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation;Cancers;2023-05-13

4. Post‐transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced‐intensity conditioning allotransplant;Clinical and Translational Medicine;2023-04

5. Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival;Bone Marrow Transplantation;2023-03-23